VCM
ZBIO

Voleon Capital Management’s Zenas BioPharma ZBIO Stock Holding History

Voleon Capital Management’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$579K Buy
29,612
+19,425
+191% +$436K 0.01% 542
2025
Q4 		$370K Buy
+10,187
New +$335K 0.01% 637

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Voleon Capital Management's ZBIO Position: Q1 2026 in Review

Voleon Capital Management increased its Zenas BioPharma (ZBIO) stake by 191% in Q1 2026, buying an estimated $436K and bringing the position to 29,612 shares worth $579K. The position accounts for 0.01% of the portfolio, ranked #542.

Voleon Capital Management first reported a position in ZBIO in Q4 2025 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Voleon Capital Management held 29,612 shares of Zenas BioPharma worth $579K as of Q1 2026.
  • Voleon Capital Management bought 19,425 Zenas BioPharma shares in Q1 2026, an estimated $436K.
  • Zenas BioPharma made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #542 holding.
  • Voleon Capital Management first reported a position in Zenas BioPharma in Q4 2025 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.